Sotera Health/$SHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sotera Health
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.
Ticker
$SHC
Sector
Primary listing
Employees
3,000
Headquarters
Website
Sotera Health Metrics
BasicAdvanced
$4.4B
184.76
$0.08
1.81
-
Price and volume
Market cap
$4.4B
Beta
1.81
52-week high
$16.75
52-week low
$9.53
Average daily volume
1.9M
Financial strength
Current ratio
2.469
Quick ratio
2.08
Long term debt to equity
449.471
Total debt to equity
460.02
Interest coverage (TTM)
2.22%
Profitability
EBITDA (TTM)
543.37
Gross margin (TTM)
55.53%
Net profit margin (TTM)
2.14%
Operating margin (TTM)
32.34%
Effective tax rate (TTM)
73.83%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
7.58%
Return on equity (TTM)
5.14%
Valuation
Price to earnings (TTM)
184.76
Price to revenue (TTM)
3.937
Price to book
8.68
Price to tangible book (TTM)
-4.97
Price to free cash flow (TTM)
39.286
Free cash flow yield (TTM)
2.55%
Free cash flow per share (TTM)
0.398
Growth
Revenue change (TTM)
2.40%
Earnings per share change (TTM)
-39.59%
3-year revenue growth (CAGR)
5.02%
3-year earnings per share growth (CAGR)
-42.29%
What the Analysts think about Sotera Health
Analyst ratings (Buy, Hold, Sell) for Sotera Health stock.
Bulls say / Bears say
Q2 2025 net revenues rose 6.4% year-over-year to $294 million and Adjusted EBITDA grew 9.8% to $151 million, driving management to raise full-year revenue growth outlook to 4.5–6.0% and EBITDA growth to 6.0–7.5% (Investing.com)
Sterigenics segment, the company’s largest, reported 10.5% revenue growth to $195 million in Q2 2025 on robust volume and pricing improvements, underpinning overall margin expansion (Finviz)
Nordion saw exceptional 35.6% revenue growth to $33 million in Q1 2025, driven by timing of Cobalt-60 shipments and mix improvements, highlighting strong segment momentum (TradingView)
Significant ethylene oxide litigation costs, including a $30.9 million settlement in April 2025, have increased SG&A expense by $6.2 million and created uncertainty over future reserves (Investing.com) (SEC 10-Q)
Nelson Labs segment revenues declined 9.3% in Q1 2025 to $52 million, reflecting weakening expert advisory services demand and offsetting gains elsewhere (TradingView)
Total debt remains elevated at $2.3 billion with net leverage of 3.5× in Q2 2025, limiting financial flexibility despite marginal improvement (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 2 Sept 2025.
Sotera Health Financial Performance
Revenues and expenses
Sotera Health Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sotera Health stock?
Sotera Health (SHC) has a market cap of $4.4B as of September 08, 2025.
What is the P/E ratio for Sotera Health stock?
The price to earnings (P/E) ratio for Sotera Health (SHC) stock is 184.76 as of September 08, 2025.
Does Sotera Health stock pay dividends?
No, Sotera Health (SHC) stock does not pay dividends to its shareholders as of September 08, 2025.
When is the next Sotera Health dividend payment date?
Sotera Health (SHC) stock does not pay dividends to its shareholders.
What is the beta indicator for Sotera Health?
Sotera Health (SHC) has a beta rating of 1.81. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.